Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Shares Issued (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Shares Issued for 11 consecutive years, with $14.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 225.77% year-over-year to $14.0 million, compared with a TTM value of $14.9 million through Dec 2025, up 399.09%, and an annual FY2025 reading of $14.9 million, up 399.09% over the prior year.
  • Shares Issued was $14.0 million for Q4 2025 at Wave Life Sciences, up from $439000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $36.9 million in Q3 2022 and bottomed at -$51.0 million in Q4 2022.
  • Average Shares Issued over 5 years is $1.0 million, with a median of $336000.0 recorded in 2021.
  • Peak annual rise in Shares Issued hit 73698.0% in 2022, while the deepest fall reached 14349.16% in 2022.
  • Year by year, Shares Issued stood at $358000.0 in 2021, then plummeted by 14349.16% to -$51.0 million in 2022, then surged by 101.0% to $509000.0 in 2023, then tumbled by 2284.87% to -$11.1 million in 2024, then surged by 225.77% to $14.0 million in 2025.
  • Business Quant data shows Shares Issued for WVE at $14.0 million in Q4 2025, $439000.0 in Q3 2025, and -$2.0 million in Q2 2025.